|
Genotype
|
Sample no. (%)
|
BDI scorea
|
Codominant p value
|
Dominant p value
|
Recessive p value
|
Log-additive p value
|
|---|
|
Total (n = 103)
|
|
TT
|
16 (15.5)
|
11.55 ± 2.90
|
0.327
|
0.382
|
0.148
|
0.170
|
|
CT
|
55 (53.4)
|
9.30 ± 1.46
| | | | |
|
CC
|
32 (31.1)
|
6.83 ± 1.79
| | | | |
|
Male (n = 36)
|
|
TT
|
5 (13.9)
|
14.00 ± 7.02
|
0.032*
|
0.174
|
0.010*
|
0.021*
|
|
CT
|
20 (55.6)
|
6.91 ± 2.56
| | | | |
|
CC
|
11 (30.6)
|
2.13 ± 0.61
| | | | |
|
Female (n = 67)
|
|
TT
|
11 (16.4)
|
10.63 ± 3.29
|
0.878
|
0.620
|
0.767
|
0.621
|
|
CT
|
35 (52.2)
|
10.50 ± 1.76
| | | | |
|
CC
|
21 (31.3)
|
9.19 ± 2.49
| | | | |
- aMean ± standard error (s.e.). The p value was adjusted for GCS, GOSE, injury mechanism, antidepressant medication use and hypnotic medication use. *p < 0.05 is labeled in bold
